Nasdaq

Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy

MONTREAL, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage ...
New York Post

I took injections to lose weight — I got a hole in my stomach instead

She wanted weight loss — but instead, she lost money and self-esteem. UK mother Julia Lanni, 58, says she bellied up about $155 last summer for 16 fat-dissolving Aqualyx injections in her stomach in ...
Finanznachrichten

FDA Approves EGRIFTATM (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients With Lipodystrophy

The efficacy and safety of EGRIFTA (TM) (tesamorelin for injection) was evaluated in two Phase 3 multi-center, randomized, double-blind, placebo-controlled clinical trials, which demonstrated ...

Considering GLP-1 pills for weight loss? Here are 8 things to know before you start

Glucagon-like peptide-1 (GLP-1) medications are now available as a pill for weight loss, offering another option beyond ...
Renal & Urology News

IV Injection for UTIs, Intra-Abdominal Infections Cleared

Doribax (doripenem injection), a 500-mg IV infusion for treating complicated UTIs (cUTI), including pyelonephritis, as well as intra-abdominal infections (cIAI), has received marketing clearance. In ...
Seeking Alpha

Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy

MONTREAL, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TH:CA) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the availability of EGRIFTA WR™ (tesamorelin) ...